Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation

Adam Doyle, Oyedele Adeyi, Korosh Khalili, Sandra Fischer, Martin Dib, Nicolas Goldaracena, Jayne Dillon, David Grant, Mark Cattral, Ian McGilvray, Paul Greig, Anand Ghanekar, Leslie Lilly, Eberhard Renner, Gary Levy, Nazia Selzner

Research output: Contribution to journalLetter

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)1295-1300
Number of pages6
JournalLiver Transplantation
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Cite this

Doyle, A., Adeyi, O., Khalili, K., Fischer, S., Dib, M., Goldaracena, N., Dillon, J., Grant, D., Cattral, M., McGilvray, I., Greig, P., Ghanekar, A., Lilly, L., Renner, E., Levy, G., & Selzner, N. (2016). Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation. Liver Transplantation, 22(9), 1295-1300. https://doi.org/10.1002/lt.24495